(Q24245722)

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR vaccine and idiopathic thrombocytopaenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Evaluation of a trivalent measles, mumps, rubella vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Childhood vaccinations and risk of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

A population-based study of measles, mumps, and rubella vaccination and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Neurologic disorders after measles-mumps-rubella vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Serological evaluation of a measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR vaccination and pervasive developmental disorders: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR Vaccination and Febrile Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Inflammatory bowel disease, autism, and the measles, mumps, and rubella vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Combined Live Measles, Mumps, and Rubella Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Safety of routine childhood vaccinations. An epidemiological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Time trends in autism and in MMR immunization coverage in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Toxic epidermal necrolysis following morbilli-parotitis-rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Case series analysis of adverse reactions to vaccines: a comparative evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR and autism: further evidence against a causal association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Idiopathic thrombocytopenic purpura and MMR vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR vaccine: review of benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Infant immunization and the occurrence of atopic disease in Dutch and German children: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR vaccination and autism 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Childhood infections as risk factors for multiple sclerosis: Belgrade case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

MMR vaccination and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

A Field Trial with a Live Measles-Mumps- Rubella Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Viral antibodies in twins with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Measles vaccination and inflammatory bowel disease in Japanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Control without separate controls: evaluation of vaccine safety using case-only methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Relation between experimental and non-experimental study designs. HB vaccines: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Global measles elimination efforts: the significance of measles elimination in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Autism, inflammatory bowel disease, and MMR vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Mumps and rubella eliminated from Finland

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Safety reporting in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 [1998] 222-226)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Optic neuritis complicating measles, mumps, and rubella vaccination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

The safety of egg-containing vaccines for egg-allergic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Adverse events following measles-mumps-rubella and measles vaccinations in college students

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Outbreak of mumps in a vaccinated child population: a question of vaccine failure?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Autism, inflammatory bowel disease, and MMR vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

1 reference

7 January 2021

Convulsions after measles immunisation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Malignant histiocytosis with slow clinical course

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Field trial of trivalent measles-rubella-mumps vaccine in Japan

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Haemolytic uraemic syndrome following mumps, measles, and rubella vaccination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Adverse reactions and mumps, measles and rubella vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

The interruption of transmission of indigenous measles in the United States during 1993

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Measles vaccine in egg allergic children: poor immunogenicity of the Edmoston-Zagreb strain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

No evidence for a new variant of measles-mumps-rubella-induced autism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

[Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021

Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004407.PUB2

7 January 2021